A citation-based method for searching scientific literature

Kelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, Dongqing Gu, Cindy Y Wen-Fong, Vu Q Nguyen, Jennifer H Han, Katrina Lowstuter, Jeffrey Longmate, Steve S Sommer, Jeffrey N Weitzel. J Clin Oncol 2009
Times Cited: 341







List of co-cited articles
723 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
Gaëlle Bougeard, Mariette Renaux-Petel, Jean-Michel Flaman, Camille Charbonnier, Pierre Fermey, Muriel Belotti, Marion Gauthier-Villars, Dominique Stoppa-Lyonnet, Emilie Consolino, Laurence Brugières,[...]. J Clin Oncol 2015
282
51

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016
185
39

A cancer family syndrome in twenty-four kindreds.
F P Li, J F Fraumeni, J J Mulvihill, W A Blattner, M G Dreyfus, M A Tucker, R W Miller. Cancer Res 1988
963
38


Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Anita Villani, Ari Shore, Jonathan D Wasserman, Derek Stephens, Raymond H Kim, Harriet Druker, Bailey Gallinger, Anne Naumer, Wendy Kohlmann, Ana Novokmet,[...]. Lancet Oncol 2016
233
32

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
D Malkin, F P Li, L C Strong, J F Fraumeni, C E Nelson, D H Kim, J Kassel, M A Gryka, F Z Bischoff, M A Tainsky. Science 1990
32

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.
Christian P Kratz, Maria Isabel Achatz, Laurence Brugières, Thierry Frebourg, Judy E Garber, Mary-Louise C Greer, Jordan R Hansford, Katherine A Janeway, Wendy K Kohlmann, Rose McGee,[...]. Clin Cancer Res 2017
195
23

P53 germline mutations in childhood cancers and cancer risk for carrier individuals.
A Chompret, L Brugières, M Ronsin, M Gardes, F Dessarps-Freichey, A Abel, D Hua, L Ligot, M G Dondon, B Bressac-de Paillerets,[...]. Br J Cancer 2000
247
22

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
J M Birch, A L Hartley, K J Tricker, J Prosser, A Condie, A M Kelsey, M Harris, P H Jones, A Binchy, D Crowther. Cancer Res 1994
407
22

2009 version of the Chompret criteria for Li Fraumeni syndrome.
Julie Tinat, Gaelle Bougeard, Stéphanie Baert-Desurmont, Stéphanie Vasseur, Cosette Martin, Emilie Bouvignies, Olivier Caron, Brigitte Bressac-de Paillerets, Pascaline Berthet, Catherine Dugast,[...]. J Clin Oncol 2009
199
21

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Marielle W G Ruijs, Senno Verhoef, Matti A Rookus, Roelof Pruntel, Annemarie H van der Hout, Frans B L Hogervorst, I Kluijt, Rolf H Sijmons, Cora M Aalfs, Anja Wagner,[...]. J Med Genet 2010
172
21

Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis.
Mandy L Ballinger, Ana Best, Phuong L Mai, Payal P Khincha, Jennifer T Loud, June A Peters, Maria Isabel Achatz, Rubens Chojniak, Alexandre Balieiro da Costa, Karina Miranda Santiago,[...]. JAMA Oncol 2017
95
22

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.
Anita Villani, Uri Tabori, Joshua Schiffman, Adam Shlien, Joseph Beyene, Harriet Druker, Ana Novokmet, Jonathan Finlay, David Malkin. Lancet Oncol 2011
250
19

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.
Fiona Lalloo, Jennifer Varley, David Ellis, Anthony Moran, Lindsay O'Dair, Paul Pharoah, D Gareth R Evans. Lancet 2003
122
19

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
19

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.
Serena Masciari, Deborah A Dillon, Michelle Rath, Mark Robson, Jeffrey N Weitzel, Judith Balmana, Stephen B Gruber, James M Ford, David Euhus, Alexandra Lebensohn,[...]. Breast Cancer Res Treat 2012
91
19

Sensitivity and predictive value of criteria for p53 germline mutation screening.
A Chompret, A Abel, D Stoppa-Lyonnet, L Brugiéres, S Pagés, J Feunteun, C Bonaïti-Pellié. J Med Genet 2001
192
17

TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data.
Liacine Bouaoun, Dmitriy Sonkin, Maude Ardin, Monica Hollstein, Graham Byrnes, Jiri Zavadil, Magali Olivier. Hum Mutat 2016
350
16

Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Magali Olivier, David E Goldgar, Nayanta Sodha, Hiroko Ohgaki, Paul Kleihues, Pierre Hainaut, Rosalind A Eeles. Cancer Res 2003
293
16

Germline mutations in the TP53 gene.
R A Eeles. Cancer Surv 1995
146
15

Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.
Shunsuke Kato, Shuang-Yin Han, Wen Liu, Kazunori Otsuka, Hiroyuki Shibata, Ryunosuke Kanamaru, Chikashi Ishioka. Proc Natl Acad Sci U S A 2003
509
15

BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
Fiona Lalloo, Jennifer Varley, Anthony Moran, David Ellis, Lindsay O'dair, Paul Pharoah, Antonis Antoniou, Roger Hartley, Andrew Shenton, Sheila Seal,[...]. Eur J Cancer 2006
98
14

Routine TP53 testing for breast cancer under age 30: ready for prime time?
Jeanna M McCuaig, Susan R Armel, Ana Novokmet, Ophira M Ginsburg, Rochelle Demsky, Steven A Narod, David Malkin. Fam Cancer 2012
53
24

High frequency of de novo mutations in Li-Fraumeni syndrome.
K D Gonzalez, C H Buzin, K A Noltner, D Gu, W Li, D Malkin, S S Sommer. J Med Genet 2009
96
13

Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.
Judy Mouchawar, Christopher Korch, Tim Byers, Todd M Pitts, Efang Li, Margaret R E McCredie, Graham G Giles, John L Hopper, Melissa C Southey. Cancer Res 2010
65
20

Lifetime cancer risks in individuals with germline PTEN mutations.
Min-Han Tan, Jessica L Mester, Joanne Ngeow, Lisa A Rybicki, Mohammed S Orloff, Charis Eng. Clin Cancer Res 2012
435
13


Li-fraumeni syndrome.
David Malkin. Genes Cancer 2011
219
12

Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
K E Nichols, D Malkin, J E Garber, J F Fraumeni, F P Li. Cancer Epidemiol Biomarkers Prev 2001
235
12

Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
Amal Melhem-Bertrandt, Jasmina Bojadzieva, Kaylene J Ready, Elias Obeid, Diane D Liu, Angelica M Gutierrez-Barrera, Jennifer K Litton, Olufunmilayo I Olopade, Gabriel N Hortobagyi, Louise C Strong,[...]. Cancer 2012
78
14

Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.
April D Sorrell, Carin R Espenschied, Julie O Culver, Jeffrey N Weitzel. Mol Diagn Ther 2013
59
18

Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers.
Simone Hettmer, Natasha M Archer, Gino R Somers, Ana Novokmet, Amy J Wagers, Lisa Diller, Carlos Rodriguez-Galindo, Lisa A Teot, David Malkin. Cancer 2014
60
18

Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
G Bougeard, R Sesboüé, S Baert-Desurmont, S Vasseur, C Martin, J Tinat, L Brugières, A Chompret, B Bressac de Paillerets, D Stoppa-Lyonnet,[...]. J Med Genet 2008
145
11

Somatic TP53 variants frequently confound germ-line testing results.
Jeffrey N Weitzel, Elizabeth C Chao, Bita Nehoray, Lily R Van Tongeren, Holly LaDuca, Kathleen R Blazer, Thomas Slavin, D A B M D Facmg, Tina Pesaran, Christina Rybak,[...]. Genet Med 2018
59
18

Li-Fraumeni syndrome: cancer risk assessment and clinical management.
Kate A McBride, Mandy L Ballinger, Emma Killick, Judy Kirk, Martin H N Tattersall, Rosalind A Eeles, David M Thomas, Gillian Mitchell. Nat Rev Clin Oncol 2014
131
10

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.
Shih-Jen Hwang, Guillermina Lozano, Christopher I Amos, Louise C Strong. Am J Hum Genet 2003
143
10


Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.
S Srivastava, Z Q Zou, K Pirollo, W Blattner, E H Chang. Nature 1990
10

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
501
10


An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.
R C Ribeiro, F Sandrini, B Figueiredo, G P Zambetti, E Michalkiewicz, A R Lafferty, L DeLacerda, M Rabin, C Cadwell, G Sampaio,[...]. Proc Natl Acad Sci U S A 2001
343
9

A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.
Saundra S Buys, John F Sandbach, Amanda Gammon, Gayle Patel, John Kidd, Krystal L Brown, Lavania Sharma, Jennifer Saam, Johnathan Lancaster, Mary B Daly. Cancer 2017
180
9

Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.
J M Varley, G McGown, M Thorncroft, L A James, G P Margison, G Forster, D G Evans, M Harris, A M Kelsey, J M Birch. Am J Hum Genet 1999
169
9

Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
Jonathan D Wasserman, Ana Novokmet, Claudia Eichler-Jonsson, Raul C Ribeiro, Carlos Rodriguez-Galindo, Gerard P Zambetti, David Malkin. J Clin Oncol 2015
96
9

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
350
9

Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome.
Chih-Chieh Wu, Sanjay Shete, Christopher I Amos, Louise C Strong. Cancer Res 2006
57
15

Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage.
Yasmine Zerdoumi, Raphaël Lanos, Sabine Raad, Jean-Michel Flaman, Gaëlle Bougeard, Thierry Frebourg, Isabelle Tournier. Hum Mol Genet 2017
20
45

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
288
9

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
849
9

Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis.
Kelvin C de Andrade, Megan N Frone, Talia Wegman-Ostrosky, Payal P Khincha, Jung Kim, Amina Amadou, Karina M Santiago, Fernanda P Fortes, Nathanaël Lemonnier, Lisa Mirabello,[...]. Hum Mutat 2019
35
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.